Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
CRISPR Therapeutics (CRSP) Q4 2023 Earnings
CRSP
21
Feb
Confirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-2.36
-1.21
-0.05
1.1
Details
Expected EPS
0.066313
Actual EPS
1.1
Surprise EPS
1.03
Surprise Percent
+1,558.8%
Description
CRISPR Therapeutics (CRSP) has reported earnings of 1.1 per share for Q4 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login